<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="other"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Med Gas Res</journal-id><journal-id journal-id-type="publisher-id">MGR</journal-id><journal-id journal-id-type="publisher-id">Med Gas Res</journal-id><journal-title-group><journal-title>Medical Gas Research</journal-title></journal-title-group><issn pub-type="epub">2045-9912</issn><publisher><publisher-name>Wolters Kluwer - Medknow</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC466985</article-id><article-id pub-id-type="publisher-id">MGR-14-153</article-id><article-id pub-id-type="doi">10.4103/2045-9912.385940</article-id><article-categories><subj-group subj-group-type="heading"><subject>Perspective</subject></subj-group></article-categories><title-group><article-title>The potential role of nitrogen dioxide inhalation in Parkinson&#x02019;s disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Li</surname><given-names>Hang</given-names></name><xref rid="aff1" ref-type="aff"/><xref rid="fn1" ref-type="author-notes">#</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Siyuan</given-names></name><xref rid="aff1" ref-type="aff"/><xref rid="fn1" ref-type="author-notes">#</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Jiahe</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>You</surname><given-names>Wanchun</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff"/><xref rid="cor1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Xu</surname><given-names>Jianguo</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0696-8197</contrib-id><xref rid="aff1" ref-type="aff"/><xref rid="cor1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Gang</given-names></name><xref rid="aff1" ref-type="aff"/></contrib></contrib-group><aff id="aff1">Department of Neurosurgery &#x00026; Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China</aff><author-notes><corresp id="cor1"><label>*</label><italic toggle="yes"><bold>Correspondence to:</bold> Jianguo Xu, <email xlink:href="xejianlov2012@gmail.com">xejianlov2012@gmail.com</email>; Wanchun You, <email xlink:href="wcyou@suda.edu.cn">wcyou@suda.edu.cn</email></italic>.</corresp><fn id="fn1"><label>#</label><p><italic toggle="yes">Both authors contributed equally to this work</italic>.</p></fn></author-notes><pub-date pub-type="collection"><season>Jul-Sep</season><year>2024</year></pub-date><pub-date pub-type="epub"><day>17</day><month>9</month><year>2023</year></pub-date><volume>14</volume><issue>3</issue><fpage>153</fpage><lpage>155</lpage><history><date date-type="received"><day>23</day><month>3</month><year>2022</year></date><date date-type="rev-recd"><day>22</day><month>5</month><year>2022</year></date><date date-type="accepted"><day>30</day><month>5</month><year>2023</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2024 Medical Gas Research</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref><license-p>This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.</license-p></license></permissions></article-meta></front><body><p>Parkinson&#x02019;s disease (PD) is a complex neurodegenerative disease in the elderly with motor and non-motor characteristics. PD is characterized by a unique set of clinical manifestations, including resting tremor, bradykinesia, and postural gait disorders. Patients may also experience non-motor symptoms such as depression, constipation and sleep disorders.<xref rid="R1" ref-type="bibr">1</xref> If the disease progresses, gradual loss of brain function and premature death may occur. PD is initially associated with the loss of nigrostriatal dopaminergic neurons, with Lewy bodies found in intact nigrostriatal cells. PD affects 1&#x02013;2% of adults over the age of 65 years and 4% of adults over the age of 80 years. Approximately 60,000 Americans are diagnosed with PD each year and there are currently more than one million Americans suffering from the disease. Given the increase in life expectancy, the amount of people living with PD is expected to increase by over 50% by 2030.<xref rid="R2" ref-type="bibr">2</xref></p><p>In the Braak phase of PD, &#x003b1;-synuclein aggregates pathologically in the olfactory bulb and gut, and then spreads to the central nervous system. In addition, risk factors for PD have been identified, such as exposure to air pollution and environmental pollutants which contains metals, pesticides and the microbiome. A previous animal study has proven that exposure to environmental particles leads to neuropathological damages to dopaminergic neurons, which is a feature of PD.<xref rid="R3" ref-type="bibr">3</xref> Reducing the burden of PD can be achieved by a two-pronged strategy: implementing measures to decrease changeable factors such as behavioral or environmental risk factors and development of drugs that target the mechanisms of pathological genes or environmental exposure related to PD.<xref rid="R4" ref-type="bibr">4</xref> Therefore, understanding the relationship between environmental risk factors and PD pathogenesis can promote relevant prevention and treatment strategies.</p><p>Due to the widespread distribution of natural and man-made sources, nitrogen dioxide (NO<sub>2</sub>) is a ubiquitous atmospheric pollutant that can cause respiratory irritation when inhaled at high level concentrations. Natural sources of NO<sub>2</sub> include volcanism, hill fire, lightning, and the stratosphere. The association between NO<sub>2</sub> exposures and sanitation is often attributed to the exposure to ultrafine particles from transport-related emissions. Jo&#x02019;s study<xref rid="R3" ref-type="bibr">3</xref> found that the increase of the risk of PD was highly associated with exposure to NO<sub>2</sub> (Hazard ratio for highest compared with lowest quartile, 1.41; 95% confidence interval, 1.02 to 1.95; <italic toggle="yes">P</italic> value of tendency = 0.045), so did another study5 that evaluated the risk of PD based on the concentration of NO<sub>2</sub>. Meanwhile, several studies have demonstrated the direct toxic effects of NO<sub>2</sub> on the central nerve system. Studies have indicated that NO<sub>2</sub> inhalation exacerbates amyloid &#x003b2;42 (A&#x003b2;<sub>42</sub>) accumulation and causes cognitive impairment through the metabolism of prostaglandin E2,<xref rid="R6" ref-type="bibr">6</xref> causes synaptic dysfunction accompanied by auopathy,<xref rid="R7" ref-type="bibr">7</xref> and increases the concentrations of pro-inflammatory markers in the brain<xref rid="R8" ref-type="bibr">8</xref> (<bold><xref rid="T1" ref-type="table">Table 1</xref></bold>). Besides, oxidative stress and systemic inflammation following the inhalation of NO<sub>2</sub> have been reported.<xref rid="R9" ref-type="bibr">9</xref> The direct toxic effects of NO<sub>2</sub> are consistent with a number of epidemiological studies suggesting associations between neurological disorders and NO<sub>2</sub>, such as stroke, PD, and amyotrophic lateral sclerosis.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>The potential role of nitrogen dioxide (NO<sub>2</sub>) in neurodegenerative diseases (including Parkinson&#x02019;s disease)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Disease</th><th align="left" rowspan="1" colspan="1">Animal</th><th align="left" rowspan="1" colspan="1">Injury type</th><th align="left" rowspan="1" colspan="1">Result</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Parkinson&#x02019;s disease</td><td align="left" rowspan="1" colspan="1">Rats</td><td align="left" rowspan="1" colspan="1">Mitochondrial dysfunction</td><td align="left" rowspan="1" colspan="1">Exposure to NO<sub>2</sub> is involved in the significant damage of mitochondrial energy metabolism and the impairment of biogenesis.</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Mice</td><td align="left" rowspan="1" colspan="1">Tau pathology</td><td align="left" rowspan="1" colspan="1">The impaired taupathy and insulin resistance are associated with NO<sub>2</sub> inhalation.</td></tr><tr><td align="left" rowspan="1" colspan="1">Neurodegenerative disease</td><td align="left" rowspan="1" colspan="1">Mice</td><td align="left" rowspan="1" colspan="1">Amyloid &#x003b2;42 accumulation aggravated</td><td align="left" rowspan="1" colspan="1">NO<sub>2</sub> inhalation contributes to the amyloid &#x003b2;42 accumulation and neuroinflammation which mediated by arachidonic acid metabolism pathway</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Oxidative stress and inflammation</td><td align="left" rowspan="1" colspan="1">NO<sub>2</sub> inhalation may induce mild inflammation occurred in the whole body and marked oxidative stress.</td></tr></tbody></table></table-wrap><p>We reviewed the related articles systematically in the online databases PubMed, Embase and Cochrane on March 3, 2022, using the following search strategies: nitrogen dioxide or nitrogen peroxide, and Parkinson&#x02019;s disease or primary parkinsonism, in various combinations as needed. In this manuscript, we explore the potential role of NO<sub>2</sub> inhalation in PD to provide insight into the pathogenic mechanisms involved and to guide possible future treatment and prevention methods.</p><p>
<bold>The potential role of NO<sub>2</sub> inhalation in mitochondrial dysfunction and excessive reactive oxygen species (ROS) generation:</bold>
</p><p>NO<sub>2</sub> is reported to be a highly concentrated pollutant that may be involved in the pathogenesis of PD and plays an important role in neuronal cell death.<xref rid="R10" ref-type="bibr">10</xref> The impairment of mitochondrial has been implicated in a number of neurological disorders, and mitochondrial production of ROS is associated with these physiological signaling cascades. The interaction of mitochondrial membrane damage with compounds disrupts the efficiency of the coupling between oxidation and phosphorylation, resulting in a large bioenergetic deficit that is essential for the survival of cells and organisms. Mitochondria generate a membrane potential in the form of a proton gradient through the inner mitochondrial membrane by using oxidizable substrates.<xref rid="R8" ref-type="bibr">8</xref> NO<sub>2</sub> exposure may induce a reduction in mitochondrial intima potential. The membrane potential provides the impetus for adenosine triphosphate synthesis, and a drop in membrane potential affects adenosine triphosphate production in cells, ultimately leading to cell death.<xref rid="R11" ref-type="bibr">11</xref> Meanwhile, after NO<sub>2</sub> inhalation, thiazolyl blue tetrazolium bromide metabolism, cytochrome C oxidase activity and the expression levels of four respiratory complex subunits are decreased, which means that mitochondrial respiratory function is affected after NO<sub>2</sub> inhalation, and mitochondrial respiratory function and neural activity are closely linked.<xref rid="R12" ref-type="bibr">12</xref> The main source of ROS production is the mitochondrial respiratory enzyme complexes. The activities of these complexes are decreased after NO<sub>2</sub> inhalation, which is an indirect indication of oxidative damage and results in loss of dopamine release from striatal axons, reduction of dendritic structures and dopamine release in the substantia nigra. After NO<sub>2</sub> inhalation, the increased malonaldehyde level and overproduction of ROS in the cortex has been confirmed in the study by Li et al.<xref rid="R10" ref-type="bibr">10</xref> These results confirm the close association between mitochondrial dysfunction or excessive ROS and NO<sub>2</sub> inhalation, which may induce neurotoxicity and finally result in PD (<bold><xref rid="F1" ref-type="fig">Figure 1</xref></bold>).</p><fig position="float" id="F1"><label>Figure 1</label><caption><p>Nitrogen dioxide (NO<sub>2</sub>) inhalation may disrupt the efficiency of the coupling between oxidation and phosphorylation, induce a decrease in mitochondrial intima potential which contributes to the decrease of adenosine triphosphate (ATP) generation.</p><p>Note: NO<sub>2</sub> can decrease the activities of mitochondrial respiratory enzyme complexes that results in excessive reactive oxygen species (ROS) generation. The decrease of ATP generation and excessive ROS generation finally result in neuron death. Created with Pathway Builder 2.0.</p></caption><graphic xlink:href="MGR-14-153-g001" position="float"/></fig><p><bold>The potential role of NO<sub>2</sub> inhalation in tau pathology and insulin resistance:</bold> Hyperphosphorylated tau protein is the main source of pathological tau inclusions that accumulate in neurogenic fibers and eventually lead to several neurodegenerative diseases such as PD.<xref rid="R13" ref-type="bibr">13</xref> Tau phosphorylation increased in the cerebral cortex and hippocampus in a dose-dependent manner after inhalation of NO<sub>2</sub>, clearly indicating that the inhalation of NO<sub>2</sub> induces taupathy by enhancing tau phosphorylation. There is evidence that accumulation of highly phosphorylated tau in the brain deletions related to tau significantly impairs the function of synapses by altering glutamate receptor expression and function. Glutamate receptor expression was reduced in the cerebral cortex and hippocampus after exposure to NO<sub>2</sub>. Based on these findings, NO<sub>2</sub> exposure shows a great association with synaptic transmission dysfunction. Tau can influence the activity of synapses by directly interacting with post-synaptic signaling complexes in addition to regulating glutamate receptor content.<xref rid="R14" ref-type="bibr">14</xref> The hyperphosphorylated tau protein, following exposure to NO<sub>2</sub>, initiates the reduction cascade of the synaptic protein. Insulin is a toxicological target of air pollutants such as NO<sub>2</sub> which can impair insulin sensitivity and induce insulin resistance, based on previous epidemiological and experimental studies.<xref rid="R15" ref-type="bibr">15</xref> Findings focusing on the function of insulin and its related receptor in the central nervous system have shown that the neuronal insulin signaling can directly regulate the tau function and disrupt intracellular insulin signaling molecules, leading to tauopathy.<xref rid="R16" ref-type="bibr">16</xref> Physiological functions of insulin are performed in various tissues targeted by insulin through several intracellular signaling cascades. The insulin receptor substrate-1/phosphoinositide-3-kinase/protein kinase B (Akt) pathway is the most remarkable cascades. Tyrosine phosphorylation of insulin receptor substrate-1 and Akt was significantly reduced after exposure to NO<sub>2</sub>, indicating the impairment of insulin signaling function. In response to inhaled NO<sub>2</sub>, abnormal tau phosphorylation helped increase glycogen synthase kinase 3&#x003b2; by Akt inhibition activity.<xref rid="R7" ref-type="bibr">7</xref> As a result, NO<sub>2</sub> inhalation contributed to the tauopathy and disturbed insulin signaling, which is also involved in mediating the insulin receptor substrate-1/Akt/glycogen synthase kinase 3&#x003b2; signaling pathway (<bold><xref rid="F2" ref-type="fig">Figure 2</xref></bold>).</p><fig position="float" id="F2"><label>Figure 2</label><caption><p>The potential mechanism of nitrogen dioxide (NO<sub>2</sub>) causing taupathy.</p><p>Note: NO<sub>2</sub> inhalation decreases tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1) and protein kinase B (AKT) and increase the level of glycogen synthase kinase 3&#x003b2; (GSK-3&#x003b2;) which finally results in taupathy and insulin signaling impairment. Created with Pathway Builder 2.0.</p></caption><graphic xlink:href="MGR-14-153-g002" position="float"/></fig><p><bold>The potential role of NO<sub>2</sub> inhalation in &#x00391;&#x003b2;<sub>42</sub> accumulation aggravated:</bold> A&#x003b2;<sub>42</sub> is one of the isoforms of A&#x003b2; that accumulates when the gene encoding amyloid precursor protein is mutated or otherwise causes an abnormal increase in &#x003b2;-secretase activity.<xref rid="R17" ref-type="bibr">17</xref> The typical pathological feature of PD is the degenerative absence of dopaminergic neurons in the substantia nigra of the midbrain.<xref rid="R18" ref-type="bibr">18</xref> A study found that A&#x003b2;<sub>42</sub> could cause progressive degeneration of dopaminergic neurons, significantly altering the morphology of dopaminergic neurons, damaging proteins and membrane structures, and leading to neuronal necrosis or apoptosis.<xref rid="R19" ref-type="bibr">19</xref> NO<sub>2</sub> inhalation was shown to selectively cause A&#x003b2;<sub>42</sub> deposition and dose-dependent impairment of mouse memory and cognitive ability. These findings suggest that inhaling NO<sub>2</sub> may enhance the production of A&#x003b2;<sub>42</sub> and lead to deterioration of spatial learning and memory. Through the Kyoto Encyclopedia of Genes and Genomes and Biocarta pathways, the significantly differentially expressed genes were mainly involved in the function of synapse and the abilities of learning and memory, including long-term potentiation/depression, the pathway of NO signaling, glutamatergic synapses, neurotrophin signaling, and the pathway of calcium signaling.<xref rid="R6" ref-type="bibr">6</xref> The arachidonic acid metabolism pathway was also involved in the Kyoto Encyclopedia of Genes and Genomes analysis. Arachidonic acid-derived prostaglandin E2, mainly derived from the cyclooxygenase-2 reaction, plays a critical role in stimulating A&#x003b2; formation, promoting neuroinflammatory responses, and regulating synaptic events (<bold><xref rid="F3" ref-type="fig">Figure 3</xref></bold>).<xref rid="R20" ref-type="bibr">20</xref> Thus, cyclooxygenase-2-mediated arachidonic acid metabolism seems to be a potential mechanism to promote neurodegenerative disease progression. Furthermore, improving the endogenous 2-arachidonoylglycerol levels by suppressing monoacylglycerol lipase effectively inhibits the neuroinflammation and accumulation of A&#x003b2; induced by the excessive release of prostaglandin E2,<xref rid="R21" ref-type="bibr">21</xref> thereby reducing the damage to spatial learning and memory caused by inhalation of NO<sub>2</sub>, which provides a mechanistic basis for treating PD-related diseases in contaminated areas.</p><fig position="float" id="F3"><label>Figure 3</label><caption><p>After nitrogen dioxide (NO<sub>2</sub>) inhalation, arachidonic acid metabolism pathway may be involved in amyloid &#x003b2;<sub>42</sub> (A&#x003b2;<sub>42</sub>) accumulation and neuroinflammation by increase the level of cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2).</p><p>Note: COX-2-mediated AA metabolism seems to be a potential mechanism to promote necrosis and Apoptosis of neuron. Created with Pathway Builder 2.0.</p></caption><graphic xlink:href="MGR-14-153-g003" position="float"/></fig><p><bold>Limitations:</bold> First of all, the real air environment is a complex system that contains various components. Therefore, previous evidence may not be sufficient to confirm the exposure response correlation between NO<sub>2</sub> and PD progression because of the different components in air pollutant mixtures. In addition, the studies included in this review investigated the potential mechanisms of NO<sub>2</sub> in PD using animal models. Further studies should focus on the relationship between pathophysiological changes of populations exposed to high-level NO<sub>2</sub> and the morbidity of PD in the future.</p><p><bold>Conclusion:</bold> With an aging population, PD urgently needs more attention. Many studies have proven that NO<sub>2</sub> can increase the incidence of PD. We need to continuously study the role of NO<sub>2</sub> in the pathophysiology of PD, so as to provide guidance for the further prevention and treatment of PD.</p><p><italic toggle="yes">Gang Chen is an Editorial Board member of Medical Gas Research. He is blindedfrom reviewing or making decisions on the manuscript. The article was subject to the journal &#x02019;s standard procedures, with peer review handled independently of this Editorial Board member and his research group</italic>.</p></body><back><ref-list><title>R<sc>EFERENCES</sc></title><ref id="R1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Simon</surname><given-names>DK</given-names></name>
<name><surname>Tanner</surname><given-names>CM</given-names></name>
<name><surname>Brundin</surname><given-names>P</given-names></name></person-group><article-title>Parkinson disease epidemiology, pathology, genetics, and pathophysiology</article-title><source>Clin Geriatr Med</source><year>2020</year><volume>36</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">31733690</pub-id>
</element-citation></ref><ref id="R2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dorsey</surname><given-names>ER</given-names></name>
<name><surname>Constantinescu</surname><given-names>R</given-names></name>
<name><surname>Thompson</surname><given-names>JP</given-names></name>
<etal/></person-group><article-title>Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030</article-title><source>Neurology</source><year>2007</year><volume>68</volume><fpage>384</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">17082464</pub-id>
</element-citation></ref><ref id="R3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jo</surname><given-names>S</given-names></name>
<name><surname>Kim</surname><given-names>YJ</given-names></name>
<name><surname>Park</surname><given-names>KW</given-names></name>
<etal/></person-group><article-title>Association of NO<sub>2</sub> and other air pollution exposures with the risk of Parkinson disease</article-title><source>JAMA Neurol</source><year>2021</year><volume>78</volume><fpage>800</fpage><lpage>808</lpage><pub-id pub-id-type="pmid">33999109</pub-id>
</element-citation></ref><ref id="R4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nandipati</surname><given-names>S</given-names></name>
<name><surname>Litvan</surname><given-names>I</given-names></name></person-group><article-title>Environmental exposures and Parkinson&#x02019;s disease</article-title><source>Int J Environ Res Public Health</source><year>2016</year><volume>13</volume><fpage>881</fpage><pub-id pub-id-type="pmid">27598189</pub-id>
</element-citation></ref><ref id="R5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>PC</given-names></name>
<name><surname>Liu</surname><given-names>LL</given-names></name>
<name><surname>Sun</surname><given-names>Y</given-names></name>
<etal/></person-group><article-title>Traffic-related air pollution increased the risk of Parkinson&#x02019;s disease in Taiwan: A nationwide study</article-title><source>Environ Int</source><year>2016</year><volume>96</volume><fpage>75</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">27614945</pub-id>
</element-citation></ref><ref id="R6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yan</surname><given-names>W</given-names></name>
<name><surname>Yun</surname><given-names>Y</given-names></name>
<name><surname>Ku</surname><given-names>T</given-names></name>
<name><surname>Li</surname><given-names>G</given-names></name>
<name><surname>Sang</surname><given-names>N</given-names></name></person-group><article-title>NO<sub>2</sub> inhalation promotes Alzheimer&#x02019;s disease-like progression: cyclooxygenase-2-derived prostaglandin E2 modulation and monoacylglycerol lipase inhibition-targeted medication</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>22429</fpage><pub-id pub-id-type="pmid">26928013</pub-id>
</element-citation></ref><ref id="R7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yan</surname><given-names>W</given-names></name>
<name><surname>Ku</surname><given-names>T</given-names></name>
<name><surname>Yue</surname><given-names>H</given-names></name>
<name><surname>Li</surname><given-names>G</given-names></name>
<name><surname>Sang</surname><given-names>N</given-names></name></person-group><article-title>NO(2) inhalation causes tauop-athy by disturbing the insulin signaling pathway</article-title><source>Chemosphere</source><year>2016</year><volume>165</volume><fpage>248</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">27657817</pub-id>
</element-citation></ref><ref id="R8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yan</surname><given-names>W</given-names></name>
<name><surname>Ji</surname><given-names>X</given-names></name>
<name><surname>Shi</surname><given-names>J</given-names></name>
<name><surname>Li</surname><given-names>G</given-names></name>
<name><surname>Sang</surname><given-names>N</given-names></name></person-group><article-title>Acute nitrogen dioxide inhalation induces mitochondrial dysfunction in rat brain</article-title><source>Environ Res</source><year>2015</year><volume>138</volume><fpage>416</fpage><lpage>424</lpage><pub-id pub-id-type="pmid">25791864</pub-id>
</element-citation></ref><ref id="R9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>H</given-names></name>
<name><surname>Han</surname><given-names>M</given-names></name>
<name><surname>Guo</surname><given-names>L</given-names></name>
<name><surname>Li</surname><given-names>G</given-names></name>
<name><surname>Sang</surname><given-names>N</given-names></name></person-group><article-title>Oxidative stress, endothelial dysfunction and inflammatory response in rat heart to NO<sub>2</sub> inhalation exposure</article-title><source>Chemosphere</source><year>2011</year><volume>82</volume><fpage>1589</fpage><lpage>1596</lpage><pub-id pub-id-type="pmid">21168897</pub-id>
</element-citation></ref><ref id="R10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>H</given-names></name>
<name><surname>Chen</surname><given-names>L</given-names></name>
<name><surname>Guo</surname><given-names>Z</given-names></name>
<name><surname>Sang</surname><given-names>N</given-names></name>
<name><surname>Li</surname><given-names>G</given-names></name></person-group><article-title>In vivo screening to determine neurological hazards of nitrogen dioxide (NO<sub>2</sub>) using Wistar rats</article-title><source>J Hazard Mater</source><year>2012</year><volume>225-226</volume><fpage>46</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">22621880</pub-id>
</element-citation></ref><ref id="R11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Leyssens</surname><given-names>A</given-names></name>
<name><surname>Nowicky</surname><given-names>AV</given-names></name>
<name><surname>Patterson</surname><given-names>L</given-names></name>
<name><surname>Crompton</surname><given-names>M</given-names></name>
<name><surname>Duchen</surname><given-names>MR</given-names></name></person-group><article-title>The relationship between mitochondrial state, ATP hydrolysis, [Mg2+]i and [Ca2+]i studied in isolated rat cardiomyocytes</article-title><source>J Physiol</source><year>1996</year><volume>496</volume><issue>1</issue><fpage>111</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">8910200</pub-id>
</element-citation></ref><ref id="R12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>Z</given-names></name>
<name><surname>Zhong</surname><given-names>C</given-names></name></person-group><article-title>Oxidative stress in Alzheimer&#x02019;s disease</article-title><source>Neurosci Bull</source><year>2014</year><volume>30</volume><fpage>271</fpage><lpage>281</lpage><pub-id pub-id-type="pmid">24664866</pub-id>
</element-citation></ref><ref id="R13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clavaguera</surname><given-names>F</given-names></name>
<name><surname>Grueninger</surname><given-names>F</given-names></name>
<name><surname>Tolnay</surname><given-names>M</given-names></name></person-group><article-title>Intercellular transfer of tau aggregates and spreading of tau pathology: Implications for therapeutic strategies</article-title><source>Neuropharmacology</source><year>2014</year><volume>76</volume><issue>A</issue><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">24050961</pub-id>
</element-citation></ref><ref id="R14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mondrag&#x000f3;n-Rodr&#x000ed;guez</surname><given-names>S</given-names></name>
<name><surname>Trillaud-Doppia</surname><given-names>E</given-names></name>
<name><surname>Dudilot</surname><given-names>A</given-names></name>
<etal/></person-group><article-title>Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation</article-title><source>J Biol Chem</source><year>2012</year><volume>287</volume><fpage>32040</fpage><lpage>32053</lpage><pub-id pub-id-type="pmid">22833681</pub-id>
</element-citation></ref><ref id="R15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thiering</surname><given-names>E</given-names></name>
<name><surname>Cyrys</surname><given-names>J</given-names></name>
<name><surname>Kratzsch</surname><given-names>J</given-names></name>
<etal/></person-group><article-title>Long-term exposure to traffic-related air pollution and insulin resistance in children: results from the GINIplus and LISAplus birth cohorts</article-title><source>Diabetologia</source><year>2013</year><volume>56</volume><fpage>1696</fpage><lpage>1704</lpage><pub-id pub-id-type="pmid">23666166</pub-id>
</element-citation></ref><ref id="R16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cole</surname><given-names>AR</given-names></name>
<name><surname>Astell</surname><given-names>A</given-names></name>
<name><surname>Green</surname><given-names>C</given-names></name>
<name><surname>Sutherland</surname><given-names>C</given-names></name></person-group><article-title>Molecular connexions between dementia and diabetes</article-title><source>Neurosci Biobehav Rev</source><year>2007</year><volume>31</volume><fpage>1046</fpage><lpage>1063</lpage><pub-id pub-id-type="pmid">17544131</pub-id>
</element-citation></ref><ref id="R17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miller</surname><given-names>DL</given-names></name>
<name><surname>Potempska</surname><given-names>A</given-names></name>
<name><surname>Wegiel</surname><given-names>J</given-names></name>
<name><surname>Mehta</surname><given-names>PD</given-names></name></person-group><article-title>High-affinity rabbit monoclonal antibodies specific for amyloid peptides amyloid-&#x003b2;40 and amyloid-&#x003b2;42</article-title><source>J Alzheimers Dis</source><year>2011</year><volume>23</volume><fpage>293</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">21116049</pub-id>
</element-citation></ref><ref id="R18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lo</surname><given-names>PS</given-names></name>
<name><surname>Rymar</surname><given-names>VV</given-names></name>
<name><surname>Kennedy</surname><given-names>TE</given-names></name>
<name><surname>Sadikot</surname><given-names>AF</given-names></name></person-group><article-title>The netrin-1 receptor DCC promotes the survival of a subpopulation of midbrain dopaminergic neurons: relevance for ageing and Parkinson's disease</article-title><source>J Neuro-chem</source><year>2022</year><volume>161</volume><fpage>254</fpage><lpage>265</lpage></element-citation></ref><ref id="R19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bouhaddi</surname><given-names>M</given-names></name>
<name><surname>Vuillier</surname><given-names>F</given-names></name>
<name><surname>Fortrat</surname><given-names>JO</given-names></name>
<etal/></person-group><article-title>Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of L-dopa therapy</article-title><source>Auton Neurosci</source><year>2004</year><volume>116</volume><fpage>30</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">15556835</pub-id>
</element-citation></ref><ref id="R20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Speed</surname><given-names>N</given-names></name>
<name><surname>Blair</surname><given-names>IA</given-names></name></person-group><article-title>Cyclooxygenase-and lipoxygenase-mediated DNA damage</article-title><source>Cancer Metastasis Rev</source><year>2011</year><volume>30</volume><fpage>437</fpage><lpage>447</lpage><pub-id pub-id-type="pmid">22009064</pub-id>
</element-citation></ref><ref id="R21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Querfurth</surname><given-names>HW</given-names></name>
<name><surname>LaFerla</surname><given-names>FM</given-names></name></person-group><article-title>Alzheimer&#x02019;s disease</article-title><source>N Engl J Med</source><year>2010</year><volume>362</volume><fpage>329</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">20107219</pub-id>
</element-citation></ref></ref-list></back></article>